Sucrosomial Iron — Competitive Intelligence Brief

Sucrosomial Iron (Sucrosomial Iron) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Hematology Small molecule

Target snapshot

Sucrosomial Iron (Sucrosomial Iron) — Cardiochirurgia E.H.. Sucrosomial iron delivers iron as a ferric hydroxide complex encapsulated in a sucrose-based matrix to improve absorption and reduce gastrointestinal side effects.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sucrosomial Iron TARGET	Sucrosomial Iron	Cardiochirurgia E.H.	marketed	Iron supplement
ferrous gluconate with lactoferrin	ferrous gluconate with lactoferrin	Ain Shams University	marketed	Iron supplement with immunomodulatory adjuvant
TOT'HEMA	TOT'HEMA	Laboratoire Innotech International	marketed	Iron supplement
Orifer F®	Orifer F®	The Hospital for Sick Children	marketed	Iron supplement with folic acid
Ferric Maltol (Feraccru®)	Ferric Maltol (Feraccru®)	Pharmanutra S.p.a.	marketed	Iron supplement	Iron (Fe³⁺) delivery via maltol chelation
Weekly Ferrous Sulfate	Weekly Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement	Iron (Fe2+) for hemoglobin synthesis
Intravenous iron supplementation	Intravenous iron supplementation	University of Pecs	marketed	Iron supplement	Iron (Fe2+/Fe3+) for hemoglobin and myoglobin synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class